Zymfentra (infliximab-dyyb) — Point32Health

Initial criteria

• Documented diagnosis of Crohn’s disease
• Patient age ≥ 18 years
• Prescribed by or in consultation with a gastroenterologist
• Documentation of ONE of the following:
• Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication required if only one is available for a listed therapeutic category):
• Interleukin Antagonists: Omvoh, Skyrizi, Tremfya, Yesintek
• Janus Kinase Inhibitors: Rinvoq
• Tumor Necrosis Factors: Cimzia, Humira
• OR Contraindication to all of the following medications: Omvoh, Skyrizi, Tremfya, Yesintek, Rinvoq, Cimzia, and Humira